Pfizer Ltd. partners with Entia Ltd to accelerate development and access to home blood monitoring device for breast cancer patients

16 September 2021

Walton Oaks and London, 16th Sept 2021: Pfizer UK has announced a partnership with British virtual oncology company, Entia, to accelerate development of a digitally enabled home blood monitoring service for breast cancer patients.

Entia’s virtual oncology platform enables patients to perform their own blood tests, with results viewable by their healthcare teams for remote monitoring. Together, Pfizer and Entia will partner to support healthcare professionals access this breakthrough innovative solution for NHS metastatic breast cancer clinics. This aims to help improve patient quality of life by reducing the burden of travelling for blood monitoring tests and unlock healthcare system capacity. The platform is currently in late stage development with required regulatory approvals anticipated for the UK and EU in early 2022.

Entia’s solution has been developed with patient and healthcare professional input through trials overseen by Europe’s largest single-site cancer centre, The Christie NHS Foundation Trust in Manchester and supported by UK Research and Innovation (UKRI). Entia’s solution includes individualised training and support for patients who use the device and data visualisation tools for healthcare professionals to ensure the solution unlocks capacity within healthcare systems and enhances the delivery of care. 

"Living with cancer is hard enough for people and so it's important that we try to relieve the burden of treatment monitoring, as well as helping our already stretched healthcare services. We're excited to partner with Entia to do this for people living with metastatic breast cancer." said Erling Donnelly, Pfizer UK Oncology Lead. “Partnering with digital health and monitoring experts such as Entia will further support Pfizer’s breakthrough therapies in an area where the burden of living with cancer is significant.”

Entia’s founder and CEO Dr. Toby Basey-Fisher said “We founded Entia with the belief that we could significantly improve the lives of people during cancer treatment. We knew that by combining virtual services with our blood monitoring technology that we could truly transform the way cancer care is delivered in a reliable way. Pfizer recognise the incredible journey we are on and how combining our approach with life-changing treatments empowers patients with even more freedom to live their life how they choose. Importantly, our approach also aims to free up capacity and streamline clinical services by integrating with existing practice.”



Contact: Harriet Cosham, Pfizer UK
0845 300 8033
[email protected]


About Pfizer: Breakthroughs That Change Patients’ Lives

At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. We strive to set the standard for quality, safety and value in the discovery, development and manufacture of health care products, including innovative medicines and vaccines. Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Consistent with our responsibility as one of the world's premier innovative biopharmaceutical companies, we collaborate with health care providers, governments and local communities to support and expand access to reliable, affordable health care around the world. For more than 170 years, we have worked to make a difference for all who rely on us. In the UK, Pfizer has its business headquarters in Surrey and is a major supplier of medicines to the NHS. To learn more about our commitments, please visit us at or follow us on Twitter (@Pfizer_UK), Facebook (@PfizerUK) and Instagram (@pfizeruk).


About Entia

Entia is making life better for people receiving cancer treatment. At Entia we work in partnership with patients and world renowned healthcare centres to deliver virtual solutions that transform cancer care. Our approach empowers patients with freedom, allowing them to reclaim their personal time, outside of healthcare settings. We help improve patient access to care whilst delivering unique insights to support better outcomes for cancer treatment.  

Please visit us at or follow us on Twitter (@Entiahealth), Facebook (@Entiahealth) and LinkedIn (@EntiaLtd)

PP-PFE-GBR-3983 / October 2021